-
Mashup Score: 3A Story of Hope For Kids With Rare Disease - TimmermanReport.com - 12 hour(s) ago
As we head into Thanksgiving, I wanted to share a story that highlights the promise and possibility that can emerge from a devastating diagnosis, and emphasizes what can happen when industry, academia, and — especially — impassioned parents and advocates join forces. Consider the devasting rare genetic disease, spinal muscular atrophy, or SMA. According to… Read More
Source: timmermanreport.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Darwin Awards: Evolutionary Action - 6 day(s) ago
Darwin Awards: Vote for the Award Nominees! The Darwin Awards commemorate the (remains of) individuals who contribute to the improvement of our gene pool by removing themselves from it. Enter this portal for stories from the Darwin Awards.
Source: darwinawards.comCategories: General Medicine News, General HCPsTweet-
Maybe, @Timodc, we're all in a massive reality show version of the Darwin Awards... https://t.co/7bSa6vd6WH https://t.co/jmSt15ehqp
-
-
Mashup Score: 4
“Does the crowd understand? Is it East versus West Or man against man? Can any nation stand alone?” Burning Heart, by Survivor – Rocky IV In national politics, the culture wars may pit the coasts against the rest of the country. In biotech, however, the AI culture war seems to pit the coasts against each… Read More
Source: timmermanreport.comCategories: General Medicine News, General HCPsTweet-
I write about the coastal culture class in AI+biotech in my latest @timmermanreport , h/t @Chandanananana @LifeSciVC and the glorious 1980s. https://t.co/q8Cu2bYiQu cc @adamjshay @zakkohane @ScottGottliebMD @VentureValkyrie
-
-
Mashup Score: 6Atlas Venture 2024 Year in Review - B. Booth - 7 day(s) ago
Atlas Venture partner and LifeSciVC author Bruce Booth shares his 2024 Year in Review. Recorded on November 7, 2024. 00:00 Introduction 01:53 Biopharma Innov…
Source: www.youtube.comCategories: General Medicine News, General HCPsTweet-
One important placeholder in the always substantive @LifeSciVC 2024 Year in Review: a cautious perspective on the impact of AI on biopharma, which he said will be "evolutionary, not revolutionary." https://t.co/ByZUAIoFaH cc @zakkohane @ScottGottliebMD @peteratmsr https://t.co/ZBhIhc5QFh
-
-
Mashup Score: 2Atlas Venture 2024 Year in Review - B. Booth - 7 day(s) ago
Atlas Venture partner and LifeSciVC author Bruce Booth shares his 2024 Year in Review. Recorded on November 7, 2024. 00:00 Introduction 01:53 Biopharma Innov…
Source: www.youtube.comCategories: General Medicine News, General HCPsTweet-
Annual year-in-review by @LifeSciVC at @atlasventure is as always an absolutely essential watch (https://t.co/tIVcPuYVVo), and a sober appraisal of scientific excitement and challenges (see this screen shot) in biotech…. https://t.co/wFF3BBhSIU
-
-
Mashup Score: 0‘Crisis Averted’ Review: What the Doctors Ordered - 10 day(s) ago
The field of public health has achieved remarkable results over the years. Covid-19 proved to be an especially tough challenge.
Source: www.wsj.comCategories: General Medicine News, General HCPsTweet-
Those seeking to understand some of the science duly recognized here might find @CadeMetz Genius Makers, which I reviewed for @wsj in 2021 together w other AI books, of particular relevance and interest: https://t.co/PekqZk3Gja @zakkohane @emollick https://t.co/7QcQpis2v4
-
-
Mashup Score: 2Third Rock-backed Trace Neuroscience Debuts with $101M, RNA Drug for ALS - TimmermanReport.com - 13 day(s) ago
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
Source: timmermanreport.comCategories: General Medicine News, General HCPsTweet-
Poignant as well as characteristically thoughtful coverage of launch of newco Trace Neuroscience (targeting ALS) by @ldtimmerman @timmermanreport , who lost his grandmother to this horrible disease: https://t.co/YNUbXfZFV1 - ~all top-tier early stage LS VCs seem represented
-
-
Mashup Score: 0the snake - 14 day(s) ago
Al Wilson – The snake..lyricsOn her way to work one morningDown the path along side the lakeA tender hearted woman saw a poor half frozen snakeHis pretty col…
Source: www.youtube.comCategories: General Medicine News, General HCPsTweet-
Appropriate soundtrack (particularly for disappointed and improbably surprised folks on center right) for listening to news about isolationist direction of cabinet appointments... https://t.co/8joWqVBiGA cc @Timodc @BillKristol (<- both NOT surprised...) @thedispatch @NRO
-
-
Mashup Score: 0Beware of Tidy Success Narratives -- in Pharma, and in Life - 14 day(s) ago
Journalists tend to celebrate deals and initiatives in part because of their inherent drama, yet this approach will inevitably skew an accurate telling of the true amount of effort required for both success and failure.
Source: www.aei.orgCategories: General Medicine News, General HCPsTweet-
Yesterday's KC/Denver game ended w KC blocking Denver FG on last play, so KC stays undefeated. Look for stories that focus on their skill, Dev shortcomings. Yet, same game except for last play could have yielded dif result-and success narratives. See: https://t.co/8wZ6EOYJt9
-
-
Mashup Score: 1
AlloVir has been reeling ever since a trio of phase 3 trial failures last year led the company to shed almost all of its staff. | AlloVir has been reeling after a trio of phase 3 trial failures last year led the company to shed almost all of its staff. Now, the immunotherapy biotech has found a new path forward by acquiring eye disease biotech Kalaris Therapeutics.
Source: www.fiercebiotech.comCategories: General Medicine News, General HCPsTweet-
Happy to see this -> https://t.co/IW6poziYwv @FierceBiotech
-
Just up at @timmermanreport - latest column celebrating a rare disease success story in SMA: https://t.co/2OwHMBcsz5 cc @smafoundation @zakkohane @adamjshay